Treatment outcome of anaplastic ependymoma under the age of 3 treated by intensity-modulated radiotherapy

Joongyo Lee, Seung Yeun Chung, Jung Woo Han, Dong Seok Kim, Jina Kim, Jin Young Moon, Hong In Yoon, Chang Ok Suh

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


Purpose: Intensity-modulated radiotherapy (IMRT) allows for more precise treatment, reducing un-wanted radiation to nearby structures. We investigated the safety and feasibility of IMRT for anaplas-tic ependymoma patients below 3 years of age. Materials and Methods: A total of 9 anaplastic ependymoma patients below 3 years of age, who received IMRT between October 2011 and December 2017 were retrospectively reviewed. The median equivalent dose in 2 Gy fractions was 52.0 Gy (range, 48.0 to 60.0 Gy). Treatment outcomes and neurologic morbidities were reviewed in detail. Results: The median patient age was 20.9 months (range, 12.1 to 31.2 months). All patients underwent surgery. The rates of 5-year overall survival, freedom from local recurrence, and progression-free survival were 40.6%, 53.3%, and 26.7%, respectively. Of the 9 patients, 5 experienced recurrences (3 had local recurrence, 1 had both local recurrence and cerebrospinal fluid [CSF] seeding, and 1 had CSF seeding alone). Five patients died because of disease progression. Assessment of neurologic morbidity revealed motor dysfunction in 3 patients, all of whom presented with hydrocephalus at initial diagnosis because of the location of the tumor and already had neurologic deficits before radiotherapy (RT). Conclusion: Neurologic morbidity is not caused by RT alone but may result from mass effects of the tumor and surgical sequelae. Administration of IMRT to anaplastic ependymoma patients below 3 years of age yielded encouraging local control and tolerable morbidities. High-precision modern RT such as IMRT can be considered for very young patients with anaplastic ependymoma.

Original languageEnglish
Pages (from-to)26-34
Number of pages9
JournalRadiation Oncology Journal
Issue number1
Publication statusPublished - 2020 Mar

Bibliographical note

Publisher Copyright:
© 2020 The Korean Society for Radiation Oncology.

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Treatment outcome of anaplastic ependymoma under the age of 3 treated by intensity-modulated radiotherapy'. Together they form a unique fingerprint.

Cite this